SOPHARMA AD: Current report 104 Maritsateks_01082013 ЕNG

opublikowano: 2013-08-01 13:11

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_104_Maritsateks_01082013_ЕNG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 104 / 2013
Date of issue: 2013-08-01
Short name of the issuer
SOPHARMA AD
Subject
Current report 104 Maritsateks_01082013 ЕNG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that:

Sopharma AD, bought 1000 shares, representing 0.21% of the capital of Maritzatex AD and as a result of this transaction the Company has crossed the threshold of 10 % of the capital of Maritzatex AD and now owns 10.12% of the capital of the latter.

The date of registration of the transaction with the Central Depository is 31 July 2013.
Annexes
File Description
Current report 104 Maritsateks_01082013 ЕNG.docCurrent report 104 Maritsateks_01082013 ЕNG.doc Current report 104 Maritsateks_01082013 ЕNG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-08-01 Ognian Donev Executive director